A b s t r a c t 28 Cancer incidence increases exponentially with age, when human telomeres are 29 shorter. Similarly, telomerase mutant zebrafish (tert) have premature short telomeres and 30 anticipate cancer incidence to younger ages. However, because short telomeres constitute a 31 road block to cell proliferation, telomere shortening is currently viewed as a tumor suppressor 32 mechanism and should protect from cancer. This conundrum is not fully understood. In our 33 current study, we report that telomere shortening promotes cancer in a non-cell autonomous 34 manner. Using zebrafish chimeras, we show increased incidence of invasive melanoma when 35 WT tumors are generated in tert mutant zebrafish. tert zebrafish show increased levels of 36 senescence (cdkn2a and ink4a/b) and inflammation (TNF-α). In addition, we transferred 37 second generation tert blastula cells into WT to produce embryo chimeras. Cells with very 38 short telomeres induced senescence and increased neutrophil numbers in surrounding larval 39 tissues in a non-cell autonomous manner, creating an inflammatory environment. Considering 40 that inflammation is pro-tumorigenic, we transplanted melanoma-derived cells into second 41 generation tert zebrafish embryos and observed that tissue environment with short telomeres 42 leads to increased micrometastasis. To test if inflammation was necessary for this effect, we 43 treated melanoma transplants with non-steroid anti-inflammatory drugs and show that higher 44 melanoma invasiveness can be averted. Thus, apart from the cell autonomous role of short 45 telomeres in contributing to genome instability, we propose that telomere shortening with age 46 causes systemic chronic inflammation leading to increased tumor incidence. 47 48 49 S i g n i f i c a n c e S t a t e m e n t 50 Cancer incidence increases exponentially in human midlife. Even though mutation 51 accumulation in somatic tissues results in increased tumorigenesis, it is currently not 52 understood how aging contributes to cancer. Telomeres, the ends of eukaryotic linear 53 chromosomes, shorten with each cell division. Here we show that telomere shortening 54 contributes to cancer in a non-cell autonomous manner. Using embryo chimeras of 55 telomerase deficient zebrafish generated from melanoma-prone fish, we show that tumors 56 arise more frequently and become more invasive in animals with shorter telomeres. Telomere 57 shortening gives rise to increased senescence and systemic inflammation. We observed 58 increased melanoma metastasis dissemination in zebrafish larvae with very short telomeres. 59
Thus, telomere shortening similar to human aging, generates a chronic inflammatory 60 environment that increases cancer incidence. 61 62 I n t r o d u c t i o n 63 Cancer incidence increases exponentially in the mid-decades of human life (1) . 64
Although mutations are required to build-up during tumorigenesis, the overall post-65 reproductive incidence opens the possibility of organism-based causes for the increase of 66 cancer with age. Due to absence of telomerase expression in most somatic tissues, telomeres 67 shorten as we grow older (2). Telomeres constitute the ends of eukaryotic chromosomes and 68 are constituted by repetitive DNA sequences (TTAGGG) n recognized by a protein complex 69 called shelterin (3). This structure prevents chromosome-ends from being recognized as 70 deleterious DNA double strand breaks while counteracting their slow attrition, resulting from 71 the "end-replication problem" by recruiting telomerase. Humans are born with telomeres 72 between 10-15 kb long (4) and, due to continuous cell divisions, telomeres may reach a 73 critical length. As cell division reaches the Hayflick limit, telomeres are recognized as DNA 74 damage and block cell proliferation either by undergoing senescence or apoptosis (5-7). 75
Since short telomeres block cell division, telomere shortening is considered as a tumor 76 suppressor mechanism by preventing excessive cell proliferation. Indeed, telomerase is 77 frequently re-activated in the majority of cancer cells, allowing for cell immortalization 78 thereby escaping replicative senescence. In line with this idea, anti-telomerase therapies are 79 currently undergoing clinical trials for cancer therapy (8). 80
Countering the tumor suppressor hypothesis, telomere shortening may lead to genome 81 instability, a hallmark of cancer. Because loss of telomere protection results in breakage-82 fusion-bridge cycles, the ensuing genome instability may contribute for age-dependent 83 tumorigenesis (9). An extreme example of the pro-tumorigenic effect of short telomeres 84 occurs in "telomeropathies". People carrying mutations in telomerase or related proteins have 85 pathologically short telomeres in early life (10, 11). Despite exhibiting pathologies related to 86 deficiencies in cell proliferation, patients also suffer from an increased cancer risk (12). 87
Similarly, our work on the telomerase mutant zebrafish, which undergoes premature telomere 88 shortening, revealed that they anticipate cancer incidence to early life (13). Even though short 89 telomeres positively correlate with increased tumorigenesis in both humans and zebrafish, it 90
is not yet understood how telomere shortening may lead to cancer. 91
Telomere shortening has consequences beyond the cellular level. As cells approach 92 replicative senescence, DNA damage emanating by short telomeres initiate a cascade of 93 events that expands to the extracellular environment. Senescent cells were shown to release a 94 set of molecules termed senescence-associated secretory phenotype (SASP) (14). SASP was 95 described in vitro and is mainly constituted by chemokines, growth factors, extra cellular 96 matrix remodelers and other inflammatory factors, capable of modulating cell environment. 97
These molecules were posteriorly shown to influence the ability of other cells to divide, 98 potentially having a pro-tumorigenic effect (15). Consistently, repeated wounding in 99 zebrafish stimulates inflammatory responses, which were shown to promote cancer 100 progression (16, 17). Therefore, we hypothesize that telomere shortening contribution to 101 tumorigenesis may have a non-cell autonomous component. In aging organisms, cells 102 undergoing replicative senescence would comprise a source of SASP/inflammatory factors 103 creating a pro-tumorigenic environment. In agreement with our hypothesis, population 104 studies have associated the long-term use of anti-inflammatory agents (acetylsalicylic acid) 105 and a reduction risk of several cancers (18-20). 106
Here we show that tissues containing cells with short telomeres promote increased 107 cancer incidence in a non-cell autonomous manner. Using chimeric zebrafish, we observed 108 that telomerase-proficient melanocytes expressing HRAS give rise to more melanoma tumors 109 when surrounded by tert mutant cells. Melanomas developed in this environment exhibited 110 high invasiveness as observed by histopathology. In agreement, using zebrafish tumor 111 transplants, we show that HRAS melanoma cells expand faster when injected into second-112 generation (G2) tert mutant larvae. Both adult G1 tert and G2 tert larvae have higher levels 113 of senescence and SASP/inflammation. G2 tert cells injected into WT embryos stimulate 114 senescence and inflammation in a non-cell autonomous manner. Chemical inhibition of 115 inflammation in G2 tert embryos rescued the invasiveness capacity of melanoma cells. Thus, 116 cells with short telomeres are capable of inducing senescence and inflammation, creating a 117 pro-tumorigenic environment that results in higher cancer invasiveness. Similar to mammals, zebrafish tumor microenvironment (TME) modulates cancer 123 behavior (21, 22). Tumors may be inhibited or enhanced as a consequence of the dynamic 124 crosstalk between cancer and surrounding cells. We, therefore, asked what were the effects of 125 a TME with short telomeres on emergent tumors. 126
In order to study the non-cell autonomous effects of TME telomere shortening in 127 cancer, we wanted to separate telomerase expression of pre-cancer cells from their 128 surrounding tissues and, for this purpose, we generated chimeric zebrafish using early-129 developmental embryo transplants. We used a melanoma zebrafish model (mitfa:HRAS) 130 developed by the Hurlstone lab that exhibits full penetrance by 3 months of age (23). We 131 chose this model since it did not require an initial tp53 dysfunction to form tumors and we 132 had previously shown that loss of p53 function rescues tert zebrafish mutants (24). Blastula 133 cells from donor embryos capable of giving rise to melanoma were transplanted into WT or 134 tert-/-recipients ( Fig 1A) . In addition, recipient embryos had a casper genetic background 135 (mitfa w2/w2 ; mpv17 a9/a9 ), and lacked the ability to produce melanocytes. Consequently, all 136 melanoma could only arise from donor cells. Embryo chimeras then were allowed to grow 137 into adulthood and studied for tumor incidence. As expected, we observed the development 138 of melanoma lesions, typically in the anal fin region of both WT and tert-/-recipient fish 139 ( Fig. 1B) . However, by 30 weeks, a time when tert-/-associated lethality is still low (<20%), 140 20% of WT chimeras developed tumors, while ca. 50% of tert-/-chimeras exhibited 141 melanoma (Fig. 1C, p<0 .05). Thus, we found that tert-/-recipients significantly increased 142 tumor incidence by ca. 2-fold (Hazard ratio after Mantel-Haenszel calculation: 2.0 when 143 compared with WT fish). 144 A possible explanation for the observed differences of tumor development in a WT 145 vs. tert-/-environment is cell competition. Wildtype tumor-prone cells could be fitter and 146 more efficient in outcompeting tert mutant recipient cells, possibly due to higher proliferation 147 rates. Thus, fitter donor cells could produce higher number of melanocytes expressing HRAS 148 in tert mutant recipients and, subsequently, lead to a higher tumor incidence. To test this 149 hypothesis, we quantified the number of melanocytes at two stages of embryo development at 150 3-and 11-days post-fertilization (dpf) in both tert mutant and WT recipients. Contrary to our 151 hypothesis, we observed no significant increase in the number of melanocytes in tert-/-152 recipients as compared to WT during developmental stages (Supplementary Figure 1A-B ). In 153 case growth differences would only be visible at later stages, we quantified the surface area 154 covered by the melanocytic lesions in adult animals. Percentage of pigmentation was 155 quantified for WT and tert-/-zebrafish (Supplementary Figure 1C -D). Similar to the results 156 obtained in larvae, although there was variation between individuals, we did not observe 157 significant differences when comparing host genotypes. Together, our data indicates that a 158 tert mutant TME increases tumor incidence in a non-cell autonomous manner, suggesting that 159 telomere shortening has a systemic role in cancer beyond the one described in genome 160 stability. 161 162 Tumors progress faster in tert mutant TME 163 Among the hallmarks of cancer, one qualitative difference between cancers relies on 164 the capacity to invade different tissues. Zebrafish chimeras bearing melanoma were analyzed 165 by histopathology and ranked according to their staging and invasiveness. Overall, 84% of 166 samples (N=43) that were macroscopically defined as tumors were confirmed as malignant 167 tumors in histopathological analysis ( Fig. 2 A-C). The remaining samples were staged as 168 benign tumors or melanosis. The large majority of tumors in tert-/-recipients were invasive 169 (80%, N=10; Fig. 2 B) . In comparison, only 22% of tumors exposed to a wildtype 170 environment (N=9) were determined as invasive ( Fig. 2 B) . A similar result was found when 171 malignant tumors were scored for the presence of cellular atypia. Cellular atypia describes 172 cytologic structural abnormalities and is a marker for more transformed cancers and more 173 advanced staging (25). Whereas 71% of tumors in a tert-/-environment (N=7) exhibited 174 moderate levels of cellular atypia ( Fig. 2 C) , all tumors in WT recipients showed low levels 175 (N=5). These results indicate that melanoma developed in tert-/-recipients progress faster, 176 reaching advanced stages faster and becoming more invasive, suggesting that TME telomere 177 shortening not only increase tumor incidence but its progression. 178 179 Zebrafish melanoma transplants are more invasive in tert mutant larvae 180
We and others have shown that injection of tumor cells in zebrafish larvae constitutes 181 an assay to study invasiveness capacity of cancer cells (26, 27). This constitutes a simpler 182 assay and allows for more expedite manipulations while being amenable to chemical studies. 183
In order to confirm that tert-/-TME promotes tumor invasiveness, we injected 184 melanoma cells derived from HRAS tumors into 2dpf WT and tert-/-larvae ( Fig. 3A) . To 185 ensure that these fish would possess cells with critically short telomeres, we used second 186 generation tert-/-(G2 tert-/-) resulting from an in-cross of young adult tert-/-zebrafish. In 187 contrast to G1 tert-/-derived from heterozygous parents, G2 tert-/-embryos possess very 188 short telomeres and a high mortality with an average longevity of ~12days (28, 29). We 189 dissected melanomas from HRAS tumors expressing GFP (see Methods) and injected cells 190
into the blood circulation of 2dpf larvae. Injected melanoma cells preferentially accumulate 191 in the tail region from where, depending on their invasiveness capacity, disseminate to 192 neighboring tissues ( Fig. 3B ). Injected larvae were individually followed over time and the 193 area occupied by GFP cells was quantified ( Fig. 3B) . 194
If an environment with short telomeres promotes tumor invasiveness, then injected 195 melanoma cells should disseminate more when injected in G2 tert-/-when compared to WT 196 larvae. We quantified the GFP-area at 1, 4 and 7 days-post injection ( Fig. 3C ). We calculated 197 the linear regression between the 3 time-points and obtained a progression slope for the 198 expansion of each grafted melanoma (N=31). We observed that tert-/-recipients allowed for 199 a more accentuated progression than the WT ones ( Telomere shortening is responsible for replicative cell senescence in human cultured cells 207 (30). Accordingly, we expected that tert-/-zebrafish would present increased levels of 208 senescence. Using RT-qPCR for specific genes, we quantified the levels of senescence in 209 tert-/-9month-old adult tissue (intestine) and 4dpf G2 tert-/-larvae (whole). As expected, the 210 senescence markers ink4a/b (p15/16) and cdkn1a (p21) levels were significantly higher in 211 both G1 tert-/-adults and G2 tert-/-larvae than in WT controls ( Fig. 4A-B ). In addition, 212 using the SA-β-Gal assay, we confirmed higher levels of senescence localized primarily in 213 the head and notochord of G2 tert-/-larvae ( Fig. 4D ). 214 Senescent cells were shown to secrete a set of molecules, known as SASP, mainly 215 composed of inflammatory factors (14, 15) . Therefore, we asked if tert-/-zebrafish present 216 signs of inflammation. We measured expression levels of TNF-α, one of the main cytokines 217 expressed during an inflammatory response, by RT-qPCR. Indeed, both G1 tert-/-adults and 218 G2 tert-/-larvae showed elevated levels of TNF-α when compared to WT (Fig. 4C ). 219
Interestingly, undisturbed 9month-old WT zebrafish exhibit higher levels of TNF-α than 220 4day-old larvae, suggesting that aging animals may respond similarly to young tert-/-221 mutants. Together, our results suggest that telomere shortening in zebrafish results in 222 increased senescence and inflammation. 223
Given the nature of the responses, we wondered if these observations originated from 224 cell-autonomous effects of tert-/-cells dispersed through the body or if tert-/-cells could 225 modulate their extracellular environment in vivo and generate a systemic response. To test if 226 short telomere tert-/-cells modulate their extracellular environment, we transplanted GFP-227 labelled G2 tert-/-cells during early-development into WT recipient embryos, thereby 228 generating larvae chimeras ( Fig. 4E ). Even though we transferred few G2 tert-/-cells into 229 developing embryos (<1% as measured by FACS of desegregated embryos at 4dpf), they 230 were sufficient to increase overall SA-β-Gal levels (Fig. 4E ). Interestingly, we observed a 231 similar pattern of SA-β-Gal staining in these chimeras as in G2 tert-/-larvae (N=22) at the 232 same stage of 4dpf (compare Fig. 4D with 4E ). These results suggest that cells derived from 233 G2 tert-/-embryos are capable of inducing senescence in a non-cell autonomous manner, thus 234 constituting an example of paracrine SASP. 235
Since senescent cells secrete pro-inflammatory molecules, we asked if G2 tert-/-cells 236 with short telomeres could create an inflammatory environment in newly generated chimeras. 237
To test this, we generated similar embryo chimeras in Tg(mpx:GFP) recipient zebrafish that 238 carry GFP-labelled neutrophils (31). As before, we injected both WT and G2 tert-/-cells 239 from embryos at blastula stage into Tg(mpx:GFP) recipient embryos of the same stage and 240 observed its effects in 4dpf larvae (Fig. 4F, right) . Whereas WT cells generated zebrafish 241 larvae (N=33) with similar numbers of neutrophils as un-injected embryos, Tg(mpx:GFP) 242 chimeras carrying G2 tert-/-cells (N=25) exhibited higher numbers of neutrophils ( Fig. 4F,  243 p=0.0075). Thus, since these innate immune cells are key to inflammatory responses, G2 tert- Inflammation can induce transformed cell growth (32). In zebrafish, PGE 2 produced 253 by innate immune cells via the COX-2 pathway was shown to act as key growth factor at the 254 earliest stages of tumor progression (16, 33). We hypothesized that the inflammatory 255 environment induced by tert-/-cells could underlie the enhanced melanoma invasiveness 256 observed in tert mutant zebrafish. To test this hypothesis, we treated the previously generated 257 zebrafish melanoma larvae allografts with non-steroid anti-inflammatory drugs (NSAIDs): 258
Aspirin (COX-1 and 2 inhibitor) and Celecoxib (COX-2 specific inhibitor). As previously, 259
we measured melanoma invasiveness by quantifying the GFP area at consecutive timepoints 260 upon melanoma cell injections (1, 4 and 7 dpi). Both WT and G2 tert-/-recipients were kept 261 in embryo medium containing Aspirin (30µM) or Celecoxib (25µM) for the duration of the 262 experiment. As previously, we calculated a progression slope of tumor cells per transplanted 263 zebrafish and compared treated vs. untreated larvae ( Fig. 5A-B ). As previously, control 264 groups showed an increased invasiveness of melanoma cells when transplanted into G2 tert-/-265 (N=31) than in WT larvae (N=32) (Fig. 5D, p= 0.0205 ). However, upon NSAID treatment, 266 the increased invasion capacity of HRAS cells in G2 tert-/-larvae (N=20) decreased to WT 267 levels (N=19) ( Fig. 5C-D of the most common alterations in cancer (35). However, cancer incidence increases 280 exponentially in the mid-ages of human life, a time when telomeres are shorter (1, 2) . In our 281 current study, we attempted to understand why cancer incidence increases when telomeres 282 are shorter. Apart from the recognized cell autonomous role in tumor suppression, we 283 propose that telomere shortening affects tumorigenesis in a non-cell autonomous manner. As 284 an organism grows older, increasing numbers of cells with short telomeres modulate their 285 surrounding environment creating a pro-inflammatory milieu that promotes tumorigenesis. 286
Using zebrafish embryo chimeras and cancer transplants, we show that incidence of 287 melanoma is not only higher but progresses faster in animals deficient for telomerase. Both 288 adult G1 tert-/-and G2 tert-/-embryos have shorter telomeres and mount DNA damage 289 responses that stabilize p53 leading to premature aging and death (13, 28, 29). Indeed, 290 mutations in tp53 rescue the severity of both tert-/-models, allowing for prolonged survival. 291
Spontaneous cancer in zebrafish, as in humans, is an age-associated disease that quickly rises 292 upon decline of reproductive age (13, 36). Like other age-related phenotypes, spontaneous 293 tumors in tert-/-zebrafish are accelerated to younger ages, while remaining similar in 294 incidence and spectrum. Indeed, telomerase deficiency and telomere shortening in zebrafish 295 do not appear to restrain tumorigenesis. Rather, they promote early cancer incidence denoting 296 a systemic role in their effects. Similarly, humans with deficiencies in telomerase and 297 premature telomere shortening show an increased cancer predisposition at younger ages (12). 298 Thus, beyond preventing uncontrolled cell proliferation, absence of telomerase and telomere 299 shortening appear to have a systemic role impairing health status and resistance to disease. 300
How could telomere shortening in surrounding tissues lead to increased incidence of 301 cancer? We observed that tert-/-zebrafish present high levels of senescence. Studies in vitro 302 revealed that senescent cells secrete SASP, composed by several inflammatory factors (14, 303 15). In agreement, we observed that tert-/-zebrafish present high levels of cdkn1a and ink4ab 304 senescence genes and TNF-α, a cytokine involved in systemic inflammation. Moreover, G2 305 tert-/-cells are capable of inducing systemic senescence and inflammation in a non-cell 306 autonomous manner. This data constitutes a strong indication that cells with short telomeres 307 are a source of paracrine SASP in vivo. However, similar to other studies in zebrafish (37), 308
we were unable to detect other typical SASP cytokines in tert-/-zebrafish larvae, such as IL6 309 and IL10. The main in vivo SASP molecules are yet to be identified in zebrafish. 310
Consistent with higher levels of inflammatory cytokines, G2 tert-/-cells containing 311 critically short telomeres can modulate their environment by increasing the number of 312
neutrophils. An increase in innate immune cells is characteristic of an inflammatory 313 environment which can be tumorigenic. Human skin cancers have been shown to increase 314 upon repeated injury and ulcers of previous lesions (38). In zebrafish, Feng et al. showed that 315 preventing the recruitment of innate immune cells reduced the growth of HRAS G12V -316 transformed cells (16). Moreover, PGE2 produced by immune cells were shown to constitute 317 a source of supportive signals for cancer cell growth. In line with this study, we observed a 318 reduction of melanoma invasiveness with anti-inflammatory treatment, such as Aspirin and 319
Celecoxib. Thus, our results suggest that G2 tert-/-cells with short telomeres promote the 320 tumor invasiveness through the COX-2 pathway. 321
Collectively, our data indicates that an environment with short telomeres promotes 322 tumorigenesis in a non-cell autonomous manner and increases the invasiveness capacity of 323 melanoma cells. Apart from the recognized cell autonomous role in blocking uncontrolled 324 cell division, telomere shortening and senescence may have a second, perhaps, antagonistic 325 pleiotropic consequence of causing local tissue damage and chronic inflammation. Thus, we 326 propose that telomere shortening during aging gives rise to a systemic inflammatory 327 environment. Chronic inflammation may be part of the mechanism whereby telomere 328 shortening leads to increase tumorigenesis with age. Indeed, whereas chronic inflammation 329 was shown to be a contributing factor in several cancers, immunosuppression leads to 330 increase the risk for certain tumors (39, 40) . Epidemiology studies associate the long-term 331 dosage of Aspirin with a reduced incidence of certain types of cancer (18-20). Interestingly, 332 this effect is more pronounced with increased age of the population. Reverting telomere 333 shortening in animal models that possess short telomeres, such as the zebrafish, will 334 conclusively test the idea if repression of telomerase promotes cancer in aging. 
Selection of Chimeras to grow and tumor assessment 390
All animals included in this study were screened for a normal phenotype, presence of 391 melanocytes and presence of GFP-positive donor cells. This screening was done under light 392 anesthesia (84μg/L tricaine methane sulfonate MS222 in E3 embryo medium, 50% of 393 standard concentration) under a Fluorescence stereomicroscope (Leica M205FA). 394
Tumor appearance was assessed weekly and macroscopically. Individual animals were scored 395 for the onset of a vertical growth phase, the presence of an outgrowth in any direction. 396
Subsequently, most animals were analyzed by histopathology to confirm tumor formation and 397 the state of invasiveness. 398
Fish preservation for histology 399
When possible, fish were food-deprived for 24h prior to processing. After sacrificing, 400 pictures of each fish were taken from both sides, both with a regular camera and at the 401 fluorescent stereoscope (Leica M205FA) to save information about the gross distribution of 402 pigmentation and chimeric (GFP+) cells. Animals were fixed in 10% neutral buffered 403 formalin for 72h at room temperature and decalcified in 0.5M EDTA for 48h. Whole fish 404 were paraffin embedded and 3μm transversal cuts were done from 5-8 regions of the fish 405 (depending on size). Cuts were stained with haematoxylin and eosin and analyzed by 406 histopathology. A total of N=18 animals was analyzed (9 WT and 9 tert-/-recipients). 407
Melanoma cell transplants into 2dpf larvae 408
Melanoma cells were derived from Tg(mitfa:HRAS G12 -mitfa:GFP) zebrafish tumors. To 409 obtain the tumor cells fish were first sacrificed with tricaine 25x and the tumor was dissected 410 with a regular scalpel and scissors. To dissociate the tumor, the mass of cells was dissected in 411 small pieces, placed in a tryplE solution and pipetted up and down. Enzymatic reaction was 412 stop with the addition of FBS (10% of total volume). Solution was filtered (70μm filter) and 413 spun down at 1700 rpm for 5 min. The pellet was re-suspended in PBS calcium/magnesium 414 free and then washed in culture medium with PBS (DMEM + 10% FBS). The final solution 415 was approximately 1x10 7 cells/mL and was obtained by removing as much as possible 416 supernatant in the last centrifugation. 417
Melanoma cells were injected into the circulation of 2dpf larvae with a microinjection 418 apparatus and needles were pulled from capillaries (TW100-4, World precision instruments). 419
Transplanted larvae were kept overnight at 28ºC in embryo media. In the following day 420 Sequence Detection System (Applied Biosystems, CA, USA). qPCRs were carried out in 455 triplicate for each cDNA sample. Relative mRNA expression was normalized to rpl13 mRNA 456 expression using the DCT method. Primer sequences are listed in Table S1 . 457
458
Table S1 -List of primers used in RT-qPCR expression analysis and tert genotyping. 459
Gene name
Primer sequences p15/16
forward -5' GGATGAACTGACCACAGCAGCA 3' reverse -5' 
